03/28/2024
3:40 PM | Coya Therapeutics (Filer)
| Form ARS | |
03/28/2024
3:30 PM | Coya Therapeutics (Filer)
| Form DEF 14A | |
03/28/2024
3:35 PM | Coya Therapeutics (Filer)
| Form DEFA14A | |
03/19/2024
7:21 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:27 AM | Coya Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:00 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:46 PM | Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
| Form SC 13G/A | |
|
02/07/2024
5:55 PM | Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
7:00 PM | Berman Howard (Reporting)
Coya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:15 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
01/04/2024
3:46 PM | Coya Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:05 PM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
7:00 AM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2023
8:46 AM | Coya Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/20/2023
7:35 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:30 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
8:03 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
8:07 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/21/2023
7:15 PM | Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:00 PM | Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2023
6:05 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:09 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2023
8:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2023
8:05 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
4:01 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:08 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:16 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
4:01 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
3:39 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
3:39 PM | Coya Therapeutics (Filer)
| Form DEFA14A | |
05/16/2023
6:47 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
3:16 PM | Coya Therapeutics (Filer)
| Form 424B4 | |
05/10/2023
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
05/10/2023
6:11 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:14 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023
8:00 AM | Coya Therapeutics (Filer)
| Form POS AM | |
